Alvotech (ALVO) Cash from Operations (2021 - 2026)
Alvotech (ALVO) posted Cash from Operations of 60429000.0 for Q1 2026, down 129.51% on a QoQ basis from 204787000.0 in Q4 2025, and down 581.54% year-over-year from 12549000.0 in Q1 2025.
Alvotech (ALVO) Cash from Operations (2021 - 2026) Analysis & Trends
Alvotech's Cash from Operations history runs 6 years deep, the most recent figure standing at 60429000.0 for Q1 2026.
- Quarterly Cash from Operations fell 581.54% year-over-year to 60429000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 65832000.0 (up 81.0% YoY) and the FY2025 annual result came in at 7146000.0, up 103.02% from the prior year.
- Cash from Operations was 60429000.0 for Q1 2026 at Alvotech, down from 204787000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 204787000.0 in Q4 2025 and bottomed at 312389000.0 in Q4 2022.
- A 5-year average of 92099933.33 and a median of 71641000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2025 — Cash from Operations soared 210.17% — and 2026, when it plunged 581.54%.
- Alvotech's Cash from Operations stood at 312389000.0 in 2022, then climbed by 0.07% to 312185000.0 in 2023, then climbed by 24.13% to 236843000.0 in 2024, then soared by 186.47% to 204787000.0 in 2025, then sank by 129.51% to 60429000.0 in 2026.
- Business Quant data shows ALVO's Cash from Operations at 60429000.0 in Q1 2026, 204787000.0 in Q4 2025, and 265932000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | -60.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.43 Mn |
| Mar 31, 2026 | -60.43 Mn |
| Dec 31, 2025 | 204.79 Mn |
| Dec 31, 2025 | 204.79 Mn |
| Sep 30, 2025 | -265.93 Mn |
| Sep 30, 2025 | -265.93 Mn |
| Jun 30, 2025 | 55.74 Mn |
| Jun 30, 2025 | 55.74 Mn |
| Mar 31, 2025 | 12.55 Mn |
| Mar 31, 2025 | 12.55 Mn |
| Dec 31, 2024 | -236.84 Mn |
| Dec 31, 2024 | -236.84 Mn |
| Sep 30, 2024 | -71.64 Mn |
| Sep 30, 2024 | -71.64 Mn |
| Jun 30, 2024 | -50.60 Mn |
| Jun 30, 2024 | -50.60 Mn |
| Mar 31, 2024 | -75.40 Mn |
| Mar 31, 2024 | -75.40 Mn |
| Dec 31, 2023 | -312.19 Mn |
| Dec 31, 2023 | -312.19 Mn |